For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...

As Roche has acquired other American biotech companies, the pharmaceutical giant has elected to keep drug making in the United States. "Taken together, I do believe this sets a stage for the next ...

Positive recommendation based on clinical, real-world and bioequivalence data supporting feasibility and safety of Phesgo’s ...

Today’s announced investments underscore our long-standing commitment to research, development and manufacturing in the US,” said Thomas Schinecker, Roche Group CEO. “We are proud of our 110 year ...

Trump hosted top CEOs at the White House to announce over $8 trillion in U.S. investments. From AI chips to steel, here’s who ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based image analysis with a level ...

Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins.

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions ...

A bruising rollercoaster ride for markets in the first 100 days of the Trump administration has seen some investors move away ...

The Swiss president says Switzerland is among 15 countries with which the United States plans to conduct “privileged” negotiations to help reach a deal in the wake of sweeping U.S. tariffs on dozens o ...